Calamos Wealth Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $266k 286k 0.93
2023-09-30 $337k 359k 0.94

More positions owned by Calamos Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 3000 Etf (IWV)
Amazon (AMZN)
Ishares Tr Core S&p Scp Etf (IJR)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Acwi Ex Us (ACWX)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
UnitedHealth (UNH)
Visa Com Cl A (V)

View all positions for Calamos Wealth Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
SSI Investment Management
CSS
Readystate Asset Management
CNH Partners

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1